| 000 | 01054 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513170415.0 | ||
| 264 | 0 | _c19990527 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0360-2532 | ||
| 024 | 7 |
_a10.1081/dmr-100101914 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJenkins, C M | |
| 245 | 0 | 0 |
_aFlavodoxin as a model for the P450-interacting domain of NADPH cytochrome P450 reductase. _h[electronic resource] |
| 260 |
_bDrug metabolism reviews _cFeb 1999 |
||
| 300 |
_a195-203 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 |
_aFlavodoxin _xchemistry |
| 650 | 0 | 4 |
_aNADH, NADPH Oxidoreductases _xchemistry |
| 650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xchemistry |
| 650 | 0 | 4 | _aProtein Conformation |
| 700 | 1 | _aWaterman, M R | |
| 773 | 0 |
_tDrug metabolism reviews _gvol. 31 _gno. 1 _gp. 195-203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/dmr-100101914 _zAvailable from publisher's website |
| 999 |
_c10025503 _d10025503 |
||